DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Blakeley JO, Ye X, Duda DG. , et al.
Efficacy and biomarker study of bevacizumab for hearing loss resulting from neurofibromatosis type 2-associated vestibular schwannomas.
J Clin Oncol 2016;
34 (14) 1669-1675
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.